A client with leukemia is receiving immunotherapy as part of their treatment plan. What is the primary purpose of immunotherapy in leukemia treatment?

A) This choice is incorrect because the lymphatic system does not filter and remove abnormal blood cells in leukemia. The role of the lymphatic system is primarily related to the circulation of lymph fluid and the immune response, not the removal of abnormal blood cells.

B) This choice is incorrect because the lymphatic system is not responsible for producing and releasing abnormal white blood cells in leukemia. Leukemia originates from the bone marrow, not the lymphatic system.

C) This choice is correct. Leukemia is primarily a disorder of the bone marrow and blood. It does not directly involve the lymphatic system, which is responsible for carrying lymph fluid and supporting the body's immune function.

D) This choice is incorrect because while cancerous cells may infiltrate other organs and tissues in other types of cancer, leukemia primarily affects the bone marrow and blood, not the lymphatic system.

Questions

A) This choice is incorrect because stimulating the production of red blood cells in the bone marrow is not the primary purpose of immunotherapy.

B) This choice is incorrect because suppressing the immune system is not the primary purpose of immunotherapy in leukemia treatment. In fact, immunotherapy aims to enhance the immune system's ability to recognize and target cancer cells.

C) This choice is correct. Immunotherapy is used to boost the body's natural defense mechanisms, particularly the immune system, to better recognize and attack leukemia cells.

D) This choice is incorrect because inhibiting the growth of cancerous tumors is not the primary purpose of immunotherapy. Other treatment approaches, such as chemotherapy or targeted therapy, may be used for this purpose.

Questions